Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?

Eli Lilly (LLY +7.51%) is benefiting from its blockbuster weight loss treatment.

*Stock prices used were the afternoon prices of June 24, 2026. The video was published on June 26, 2026.

Parkev Tatevosian, CFA has positions in Eli Lilly. The Motley Fool has positions in and recommends Eli Lilly. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top